Nerizonate

Drug GRT US Holding, Inc.
Total Payments
$290,129
Transactions
181
Doctors
8
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2018 $290,129 181 8

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $263,427 140 90.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,000 6 6.2%
Travel and Lodging $7,311 20 2.5%
Food and Beverage $1,391 15 0.5%

Payments by Type

Research
$263,427
140 transactions
General
$26,702
41 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
KF7013-02 GRT US Holding, Inc. $263,427 2

Top Doctors Receiving Payments for Nerizonate

Doctor Specialty Location Total Records
Unknown — Cerritos, CA $258,407 138
, M.D Pain Medicine Los Angeles, CA $6,556 7
, MD Pain Medicine Seattle, WA $5,287 8
Asokumar Buvanendran Anesthesiology Chicago, IL $4,716 8
, MD,PHD Neurology Cleveland, OH $4,038 7
, MD Neonatal-Perinatal Medicine Washington, DC $3,970 1
, M.D Anesthesiology Lutherville, MD $3,413 8
, MD Rheumatology Philadelphia, PA $2,691 3
Richard Rauck — Winston Salem, NC $1,050 1

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $290,129
  • Total Doctors 8
  • Transactions 181

About Nerizonate

Nerizonate is a drug associated with $290,129 in payments to 8 healthcare providers, recorded across 181 transactions in the CMS Open Payments database. The primary manufacturer is GRT US Holding, Inc..

Payment data is available from 2018 to 2018. In 2018, $290,129 was paid across 181 transactions to 8 doctors.

The most common payment nature for Nerizonate is "Unspecified" ($263,427, 90.8% of total).

Nerizonate is associated with 1 research study, including "KF7013-02" ($263,427).